biological preparations made from human blood cells for gene therapy; biological preparations made from living tissues for use in gene therapy; biolog Read More

Classification Information

Class [005]
Biological preparations made from human blood cells for gene therapy; biological preparations made from living tissues for use in gene therapy; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular pharmaceuticals; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic reagents and agents for medical diagnostic use; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; nutritional additives for medical purposes namely for promoting general health and well-being, used in foods and dietary supplements for human consumption; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for use in gene therapy; pharmaceutical products for treating respiratory diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprised of living tissues; surgical implants grown from stem cells; synthetic peptides for pharmaceutical purposes

Classification kind code

Class [010]
Medical apparatus and instruments for amplifying nucleic acid DNA and RNA molecules; medical apparatus for facilitating the inhalation of pharmaceutical preparations; medical apparatus for intravenous administration of fluids, namely, fluid warmers; medical devices for the qualitative detection of antibodies in human specimens collected as plasma or dried blood spots; medical instruments for taking human blood, cell, saliva, urine and sputum sample specimens for medical purposes; robotic arms for thoracic and cardiovascular surgery; surgical implants comprised of artificial materials for use in guided tissue regeneration

Classification kind code

Class [042]
Analysis of human tissues and stem cells for scientific research purposes; analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; bacteriological research; biological therapeutic research services; biomedical research services; chemical research; conducting early evaluations in the field of new pharmaceuticals; conducting research, development, and evaluations in the field of new pharmaceuticals; development of new technological products for others in the field biotechnology; development of pharmaceutical preparations and medicines; drug discovery services; medical research laboratory services; medical research services; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the field of clinical trials; regenerative medicine advice and scientific research for third parties; research and development in the medical biotechnology field; research and development in the pharmaceutical and proteomics fields; research and development of new products for others; research and development of vaccines and medicines; scientific research and development of precision therapies for cardiovascular diseases and cancers; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research services in the field of gene therapy; testing of human tissues and stem cells for scientific research purposes

Classification kind code

Class [044]
Analysis and processing of blood plasma and stem cells being medical services; gene therapy services; information, advisory and consultancy services in the field of medical care and analysis services; medical services relating to the removal, treatment and processing of stem cells; medical testing for diagnostic or treatment purposes; regenerative medicine services; stem cell therapy services

Classification kind code

Mark Details

Serial Number

2348895

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 30 on 11^th Sep 2024	Filed
Submitted for opposition 1 on 11^th Sep 2024	Created
Submitted for opposition 31 on 11^th Sep 2024	Formalized